NCT06044584 Unveiling Physiological and Psychosocial Pain Components with an Artificial Intelligence Based Telemonitoring Tool
| NCT ID | NCT06044584 |
| Status | Recruiting |
| Phase | — |
| Sponsor | ETH Zurich |
| Condition | Nociceptive Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2023-09-29 |
| Primary Completion | 2028-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2023-09-29 with a primary completion date of 2028-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The pAIn-sense study aims to revolutionize the monitoring and treatment of chronic pain, a major health concern that significantly impacts psychological well-being and quality of life. Traditional approaches to pain management face challenges like unspecific drug use and high healthcare costs, and they often leave patients dissatisfied. PAIn-sense aims at comprehensively understanding pain from both physical and emotional perspectives. To accomplish this, the study will employ advanced Artificial Intelligence (AI) techniques and wearable sensing technology. The study aims to monitor patients continuously, during both day and night activities, to gather a multidimensional set of data on their physiological, psychosocial, and pain conditions.
Eligibility Criteria
Inclusion Criteria: * Ongoing nociceptive pain after an injury or Neuropathic pain (acute or chronic) * Familiar with using electronic devices Exclusion Criteria: * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. * Unable or not willing to give informed consent
Contact & Investigator
Stanisa Raspopovic, PhD
PRINCIPAL INVESTIGATOR
ETH Zurich
Frequently Asked Questions
Who can join the NCT06044584 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Nociceptive Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06044584 currently recruiting?
Yes, NCT06044584 is actively recruiting participants. Contact the research team at andrea.cimolato@gmail.com for enrollment information.
Where is the NCT06044584 trial being conducted?
This trial is being conducted at Pietra Ligure, Italy, Zurich, Switzerland, Zurich, Switzerland, Sion, Switzerland.
Who is sponsoring the NCT06044584 clinical trial?
NCT06044584 is sponsored by ETH Zurich. The principal investigator is Stanisa Raspopovic, PhD at ETH Zurich. The trial plans to enroll 150 participants.